GI and Liver Association of the Americas (GALA) Tri-State Conference
GI and Liver Association of the Americas (GALA) Tri-State Conference is organized by GI and Liver Association of the Americas (GALA) and will be held from Jun 19 - 20, 2020 at Hyatt Regency Jersey City on the Hudson, Jersey City, New Jersey, United States of America.
Gastroenterologists, hepatologists, internists, family practitioners, surgeons, physician assistants, nurse practitioners, fellows/residents in training, registered nurses, and other healthcare professionals with an interest in GI and liver diseases.
The Annenberg Center for Health Sciences at Eisenhower designates this live activity for a maximum of 11.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The Annenberg Center for Health Sciences at Eisenhower is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.
A maximum of 10.6 contact hours may be earned for successful completion of this activity.
ABIM Maintenance of Certification (MOC) Points
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 11.0 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
This CME conference is guaranteed to provide a comprehensive update on GI and liver diseases from renowned faculty. The 1.5-day conference will have a strong focus on viral hepatitis, NAFLD/NASH, primary biliary cirrhosis, drug-induced liver injury, complications of portal hypertension, including hepatic encephalopathy and thrombocytopenia, hepatocellular carcinoma, GERD, chronic pancreatitis, fecal incontinence, and irritable bowel syndrome.
Statement of Need / Program Overview:
Digestive diseases include a wide spectrum of disorders affecting the oropharynx and alimentary canal, liver and biliary system, and pancreas. Chronic GI disorders are common in the US, and the prevalence is increasing. Considerable overlap can be found in the symptoms of serious GI diseases and the symptoms of benign or functional GI diseases. Noninvasive diagnostic tests, sensible clinical evaluation plans, and a clear understanding of disease progression will enhance patient assessment/management and identify the right patients for referral to GI specialists. For patients with a confirmed diagnosis of a chronic GI disorder, advances in the understanding of the clinical impact of evolving treatment options offer new choices for managing these conditions.
The conference format will consist of lectures, Q&A/panel discussions, and parallel breakout sessions for in-depth discussions of high-interest topics.
CME Leaning Objectives:
Upon completion of this conference, participants should be better able to:
• Describe evolving patient management and treatment strategies for CLD and GI disorders
• Integrate significant advances in therapeutic and diagnostic modalities into clinical practice
• Apply the latest clinical research, including future therapies and their role in the context of the current clinical paradigm
|Contact No. :||973-525-1508
|Registration Type||Last Date||Price|
|Physician Early Fee||01 Apr,2020||USD 100.00|
|Nurse Practitioner Early Fee||01 Apr,2020||USD 50.00|
|Physician Assistant Early Fee||01 Apr,2020||USD 50.00|
|RN, LVN, LPN Early Fee||01 Apr,2020||USD 50.00|
|PhD Early Fee||01 Apr,2020||USD 50.00|
|PharmD Early Fee||01 Apr,2020||USD 50.00|
|Industry Representative Early Fee||01 Apr,2020||USD 150.00|
|Other Early Fee||01 Apr,2020||USD 50.00|